论文部分内容阅读
目的:探讨痰热清注射液联合阿奇霉素序贯治疗儿童支原体肺炎的临床疗效。方法:选取2016年1月至2017年2月我院收治的儿童支原体肺炎患儿96例,按随机数字表法分为2组,对照组48例患儿,采取阿奇霉素质量,观察组48例患儿,在对照组治疗基础上联合痰热清注射液治疗,均治疗10~14d后,比较两组治疗效果及用药安全性。结果:观察组治疗总有效率高于对照组(P<0.05);且无明显不良反应发生。结论:对支原体肺炎患儿在阿奇霉素治疗基础上联合痰热清注射液治疗的效果较好,且用药安全。
Objective: To investigate the clinical efficacy of Tanreqing injection and azithromycin sequential treatment of children with mycoplasma pneumonia. Methods: A total of 96 children with mycoplasma pneumonia admitted in our hospital from January 2016 to February 2017 were divided into two groups according to the random number table method, and 48 children in the control group were treated with azithromycin. 48 patients in the observation group Children in the control group based on the combination of Tanreqing injection treatment, were treated 10 ~ 14d, the two groups were compared the therapeutic effect and medication safety. Results: The total effective rate of observation group was higher than that of control group (P <0.05). No obvious adverse reactions occurred. Conclusion: Mycoplasma pneumonia in children on the basis of azithromycin combined with Tanreqing injection treatment is better, and medication safety.